Providers Lose 340B Lawsuit Appeal To Drug Makers
A U.S. Court of Appeals ruled that drug makers can limit and impose conditions on pharmacies participating in the 340B drug discount program. The federal government had sided with providers, but a federal court ruled against that position.
I am no friend of drug makers but this ruling is a good one. The 340B program has been corrupted and abused by providers. It is not fulfilling its mission of getting discounted drugs to the most vulnerable.
Additional article: https://insidehealthpolicy.com/inside-drug-pricing-daily-news/second-appeals-court-rules-drug-makers-can-impose-340b-restrictions
(Some articles may require a subscription.)
#340b #drugmakers #hospitals #providers
